Browse by UCL Departments and Centres
Group by: Author | Type
Number of items: 132.
A
Aaboud, M;
Aad, G;
Abbott, B;
Abdinov, O;
Abeloos, B;
Abhayasinghe, DK;
Abidi, SH;
... Zwalinski, L; + view all
(2019)
Searches for scalar leptoquarks and differential cross-section measurements in dilepton-dijet events in proton-proton collisions at a centre-of-mass energy of root s=13TeV with the ATLAS experiment.
The European Physical Journal C
, 79
, Article 733. 10.1140/epjc/s10052-019-7181-x.
|
Abeti, R;
Baccaro, A;
Giunti, P;
(2019)
Mitochondrial Dysfunction in Friedreich Ataxia.
In: Ahmad, SI, (ed.)
Handbook of Mitochondrial Dysfunction.
CRC Press: Boca Raton, FL, USA.
|
Agostinelli, C;
Akarca, AU;
Ramsay, A;
Rizvi, H;
Rodriguez-Justo, M;
Pomplun, S;
Proctor, I;
... Marafioti, T; + view all
(2019)
Novel markers in pediatric-type follicular lymphoma.
Virchows Archiv
10.1007/s00428-019-02681-y.
(In press).
|
Ahmedzai, SH;
Snowden, JA;
Ashcroft, AJ;
Cairns, DA;
Williams, C;
Hockaday, A;
Cavenagh, JD;
... Cook, G; + view all
(2019)
Patient-Reported Outcome Results From the Open-Label, Randomized Phase III Myeloma X Trial Evaluating Salvage Autologous Stem-Cell Transplantation in Relapsed Multiple Myeloma.
Journal of Clinical Oncology
, 37
(19)
pp. 1617-1628.
10.1200/jco.18.01006.
|
Ankcorn, MJ;
Fox, TA;
Ijaz, S;
Nicholas, C;
Houston, E;
Longair, I;
Suri, D;
... Sekhar, M; + view all
(2019)
Characterising the risk of Hepatitis E virus infection in haematological malignancies: a UK prospective prevalence study.
British Journal of Haematology
, 186
(1)
pp. 191-195.
10.1111/bjh.15796.
|
Aswendt, M;
Vogel, S;
Schaefer, C;
Jathoul, A;
Pule, M;
Hoehn, M;
(2019)
Quantitative in vivo dual-color bioluminescence imaging in the mouse brain.
Neurophotonics
, 6
(2)
, Article 025006. 10.1117/1.NPh.6.2.025006.
|
Avenali, M;
Toffoli, M;
Mullin, S;
McNeil, A;
Hughes, DA;
Mehta, A;
Blandini, F;
(2019)
Evolution of prodromal parkinsonian features in a cohort of GBA mutation-positive individuals: a 6-year longitudinal study.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2019-320394.
(In press).
|
B
Banerjee, G;
Chan, E;
Ambler, G;
Wilson, D;
Cipolotti, L;
Shakeshaft, C;
Cohen, H;
... Vahidassr, D; + view all
(2019)
Effect of small-vessel disease on cognitive trajectory after atrial fibrillation-related ischaemic stroke or TIA.
Journal of Neurology
, 266
(5)
pp. 1250-1259.
10.1007/s00415-019-09256-6.
|
Bazarbachi, A;
Boumendil, A;
Finel, H;
Mohty, M;
Castagna, L;
Blaise, D;
Peggs, KS;
... Sureda, A; + view all
(2019)
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party.
Cancer
, 125
(1)
pp. 90-98.
10.1002/cncr.31755.
|
Bennett, CL;
Ambler, CA;
(2019)
Editorial: Langerhans Cells and How Skin Pathology Reshapes the Local Immune Environment.
Frontiers in Immunology
, 10
, Article 139. 10.3389/fimmu.2019.00139.
|
Biswas, D;
Birkbak, NJ;
Rosenthal, R;
Hiley, CT;
Lim, EL;
Papp, K;
Boeing, S;
... TRACERx Consortium; + view all
(2019)
A clonal expression biomarker associates with lung cancer mortality.
Nature Medicine
, 25
pp. 1540-1548.
10.1038/s41591-019-0595-z.
|
Boire, A;
Coffelt, SB;
Quezada, SA;
Vander Heiden, MG;
Weeraratna, AT;
(2019)
Tumour Dormancy and Reawakening: Opportunities and Challenges.
Trends in Cancer
, 5
(12)
pp. 762-765.
10.1016/j.trecan.2019.10.010.
|
Bridgewater, J;
(2019)
Systemic treatment of biliary tract cancer: now we have evidence.
Annals of Oncology
, 30
(12)
pp. 1851-1852.
10.1093/annonc/mdz441.
|
Burt, R;
Dey, A;
Aref, S;
Aguiar, M;
Akarca, A;
Bailey, K;
Day, W;
... Fielding, AK; + view all
(2019)
Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress.
Blood
, 134
(17)
pp. 1415-1429.
10.1182/blood.2019001398.
|
Burt, R;
Warcel, D;
Fielding, AK;
(2019)
Blinatumomab, a bispecific B-cell and T-cell engaging antibody, in the treatment of B-cell malignancies.
Human Vaccines & Immunotherapeutics
, 15
(3)
pp. 594-602.
10.1080/21645515.2018.1540828.
|
C
Cappellini, MD;
Porter, J;
Origa, R;
Forni, GL;
Voskaridou, E;
Galacteros, F;
Taher, AT;
... Hermine, O; + view all
(2019)
Sotatercept, a novel transforming growth factor beta ligand trap, improves anemia in beta-thalassemia: a phase II, open-label, dose-finding study.
Haematologica
, 104
(3)
pp. 477-484.
10.3324/haematol.2018.198887.
|
Chan, JKY;
Gil-Farina, I;
Johana, N;
Rosales, C;
Tan, YW;
Ceiler, J;
Mcintosh, J;
... Mattar, CNZ; + view all
(2019)
Therapeutic expression of human clotting factors IX and X following adeno-associated viral vector-mediated intrauterine gene transfer in early-gestation fetal macaques.
FASEB Journal
, 33
(3)
pp. 3954-3967.
10.1096/fj.201801391R.
|
Chan, TA;
Yarchoan, M;
Jaffee, E;
Swanton, C;
Quezada, SA;
Stenzinger, A;
Peters, S;
(2019)
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic.
Annals of Oncology
, 30
(1)
pp. 44-56.
10.1093/annonc/mdy495.
|
Chavda, SJ;
Maciocia, PM;
Mesiri, P;
Counsell, N;
Kothari, J;
Bird, A;
Mariner, C;
... Yong, K; + view all
(2019)
A new prognostic model for myeloma patients relapsing from upfront autologous transplantation based on ISS and PFS1.
British Journal of Haematology
, 185
(2)
pp. 350-353.
10.1111/bjh.15487.
|
Chemaly, RF;
Hill, JA;
Voigt, S;
Peggs, KS;
(2019)
In vitro comparison of currently available and investigational antiviral agents against pathogenic human double-stranded DNA viruses: A systematic literature review.
Antiviral Research
, 163
pp. 50-58.
10.1016/j.antiviral.2019.01.008.
|
Chemi, F;
Rothwell, DG;
McGranahan, N;
Gulati, S;
Abbosh, C;
Pearce, SP;
Zhou, C;
... TRACERx Consortium, .; + view all
(2019)
Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse.
Nature Medicine
, 25
pp. 1534-1539.
10.1038/s41591-019-0593-1.
|
Christen, F;
Hoyer, K;
Yoshida, K;
Hou, H-A;
Waldhueter, N;
Heuser, M;
Hills, RK;
... Damm, F; + view all
(2019)
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients.
Blood
, 133
(10)
pp. 1140-1151.
10.1182/blood-2018-05-852822.
|
Cohen, H;
Mackie, IJ;
Devreese, KMJ;
(2019)
Clinical and laboratory practice for lupus anticoagulant testing: An International Society of Thrombosis and Haemostasis Scientific and Standardization Committee survey.
Journal of Thrombosis and Haemostasis
, 17
(10)
pp. 1715-1732.
10.1111/jth.14560.
|
Cohen, OC;
Counsell, N;
Rabin, N;
Popat, R;
Owen, RG;
Popova, B;
Schofield, O;
... Yong, KL; + view all
(2019)
Bortezomib consolidation post-ASCT as frontline therapy for multiple myeloma deepens disease response and MRD-negative rate whilst maintaining QOL and response to re-treatment at relapse.
[Letter].
British Journal of Haematology
, 185
(5)
pp. 948-951.
10.1111/bjh.15649.
|
Cook, G;
Royle, K-L;
O'Connor, S;
Cairns, DA;
Ashcroft, AJ;
Williams, CD;
Hockaday, A;
... National Cancer Research Institute Haemato-oncology Clinical Stu; + view all
(2019)
The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.
British Journal of Haematology
10.1111/bjh.15782.
(In press).
|
Coughtrey, AE;
Shafran, R;
Su, MT;
Allcott-Watson, H;
Christie, D;
Hough, R;
(2019)
Health Professionals' Perspectives on the Nature of Distress and Low Mood in Young People with Cancer.
Journal of Adolescent and Young Adult Oncology
, 8
(2)
pp. 190-196.
10.1089/jayao.2018.0082.
|
Creary, LE;
Guerra, SG;
Chong, W;
Brown, CJ;
Turner, TR;
Robinson, J;
Bultitude, WP;
... Fernandez-Vina, MA; + view all
(2019)
Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop.
Human Immunology
, 80
(7)
pp. 449-460.
10.1016/j.humimm.2019.03.001.
|
Cuadrado, MM;
Szydlo, RM;
Watts, M;
Patel, N;
Renshaw, H;
Dorman, J;
Lowdell, M;
... Chakraverty, R; + view all
(2019)
Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function.
Haematologica
, 105
(11)
10.3324/haematol.2019.226340.
|
Cuff, AO;
Sillito, F;
Dertschnig, S;
Hall, A;
Tu, VL;
Chakraverty, R;
Male, V;
(2019)
The Obese Liver Environment Mediates Conversion of NK Cells to a Less Cytotoxic ILC1-Like Phenotype.
Frontiers in Immunology
, 10
, Article 2180. 10.3389/fimmu.2019.02180.
|
D
Dagil, L;
Troelsen, KS;
Bolt, G;
Thim, L;
Wu, B;
Zhao, X;
Tuddenham, EGD;
... Hansen, DF; + view all
(2019)
Interaction Between the a3 Region of Factor VIII and the TIL'E’ Domains of the von Willebrand Factor.
Biophysical Journal
, 117
(3)
pp. 479-489.
10.1016/j.bpj.2019.07.007.
|
Das-Gupta, E;
Thomson, KJ;
Bloor, AJC;
Clark, AD;
Mackinnon, S;
Kayani, I;
Clifton-Hadley, L;
... Peggs, KS; + view all
(2019)
Allo-HSCT in transplant-naive patients with Hodgkin lymphoma: a single-arm, multicenter study.
Blood Advances
, 3
(24)
pp. 4264-4270.
10.1182/bloodadvances.2019001016.
|
Dodagatta-Marri, E;
Meyer, DS;
Reeves, MQ;
Paniagua, R;
To, MD;
Binnewies, M;
Broz, ML;
... Akhurst, RJ; + view all
(2019)
α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas.
Journal for ImmunoTherapy of Cancer
, 7
, Article 62. 10.1186/s40425-018-0493-9.
|
Donald, A;
Cizer, H;
Finnegan, N;
Collin-Histed, T;
Hughes, DA;
Davies, EH;
(2019)
Measuring disease activity and patient experience remotely using wearable technology and a mobile phone app: outcomes from a pilot study in Gaucher disease.
Orphanet Journal of Rare Diseases
, 14
, Article 212. 10.1186/s13023-019-1182-6.
|
Drayson, MT;
Bowcock, S;
Planche, T;
Iqbal, G;
Pratt, G;
Yong, K;
Wood, J;
... Dunn, JA; + view all
(2019)
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.
The Lancet Oncology
, 20
(12)
pp. 1760-1772.
10.1016/S1470-2045(19)30506-6.
|
Drayson, MT;
Bowcock, S;
Planche, T;
Iqbal, G;
Pratt, G;
Yong, K;
Wood, J;
... Dunn, JA; + view all
(2019)
Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.
Health Technology Assessment
, 23
(62)
10.3310/hta23620.
|
E
Efthymiou, M;
Mackie, IJ;
Lane, PJ;
Andrade, D;
Willis, R;
Erkan, D;
Sciascia, S;
... APS ACTION, .; + view all
(2019)
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository.
Journal of Thrombosis and Haemostasis
, 17
(12)
pp. 2069-2080.
10.1111/jth.14596.
|
El-Sharkawi, D;
Ng, C-H;
Payne, EMC;
Yong, KL;
Ardeshna, KM;
Khwaja, A;
Townsend, W;
(2019)
Clinical outcomes and survival of patients with myeloma and lymphoma enrolled into phase I clinical trials.
British Journal of Haematology
, 185
(2)
pp. 344-347.
10.1111/bjh.15457.
|
Engelhardt, M;
Yong, K;
Bringhen, S;
Waesch, R;
(2019)
Carfilzomib combination treatment as first-line therapy in multiple myeloma: where do we go from the Carthadex (KTd)-trial update?
[Editorial comment].
Haematologica
, 104
(11)
pp. 2128-2131.
10.3324/haematol.2019.228684.
|
Evans, REC;
Taylor, SA;
Kalasthry, J;
Sakai, NS;
Miles, A;
Streamline investigators;
(2019)
Patient deprivation and perceived scan burden negatively impact the quality of whole-body MRI.
Clinical Radiology
10.1016/j.crad.2019.10.019.
(In press).
|
Eyre, TA;
Kirkwood, AA;
Gohill, S;
Follows, G;
Walewska, R;
Walter, H;
Cross, M;
... the UK CLL Forum; + view all
(2019)
Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post-BCR inhibitor setting: a UK wide analysis.
British Journal of Haematology
, 185
(4)
pp. 656-669.
10.1111/bjh.15802.
|
F
Ferrer, IR;
West, HC;
Henderson, S;
Ushakov, DS;
Santos E Sousa, P;
Strid, J;
Chakraverty, R;
... Bennett, CL; + view all
(2019)
A wave of monocytes is recruited to replenish the long-term Langerhans cell network after immune injury.
Science Immunology
, 4
(38)
, Article eaax8704. 10.1126/sciimmunol.aax8704.
|
Fielding, AK;
(2019)
Curing Ph+ ALL: assessing the relative contributions of chemotherapy, TKIs, and allogeneic stem cell transplant.
Hematology, the ASH Education Program
, 2019
(1)
pp. 24-29.
10.1182/hematology.2019000010.
|
Fielding, AK;
(2019)
En-Abl-ing treatment of “Ph-like” ALL?
Blood
, 134
(16)
pp. 1277-1278.
10.1182/blood.2019002621.
|
Fox, TA;
Carpenter, B;
Khwaja, A;
Halsey, R;
Grandage, V;
Mansour, MR;
Fielding, AK;
(2019)
Utility of FDG-PET/CT in Lymphoblastic Lymphoma.
Presented at: 61st ASH Annual Meeting, Orlando, FL, USA.
|
Franz Demane, Dafne Sofia;
(2019)
Defining and targeting combination immunotherapies in mouse models of cancer.
Doctoral thesis (Ph.D), UCL (University College London).
|
G
Gardiner, C;
Lane, P;
Tailor, H;
Mackie, IJ;
(2019)
A practical method for reducing the interference due to lipaemia in coagulation tests.
International Journal of Laboratory Hematology
, 42
(2)
pp. 140-144.
10.1111/ijlh.13129.
|
Germain, DP;
Arad, M;
Burlina, A;
Elliott, PM;
Falissard, B;
Feldt-Rasmussen, U;
Hilz, MJ;
... Spada, M; + view all
(2019)
The effect of enzyme replacement therapy on clinical outcomes in female patients with Fabry disease - A systematic literature review by a European panel of experts.
Molecular Genetics and Metabolism
, 126
(3)
pp. 224-235.
10.1016/j.ymgme.2018.09.007.
|
Germain, DP;
Nicholls, K;
Giugliani, R;
Bichet, DG;
Hughes, DA;
Barisoni, LM;
Colvin, RB;
... Viereck, C; + view all
(2019)
Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study.
Genetics in Medicine
10.1038/s41436-019-0451-z.
(In press).
|
Ghorashian, S;
Kramer, AM;
Onuoha, S;
Wright, G;
Bartram, J;
Richardson, R;
Albon, SJ;
... Amrolia, PJ; + view all
(2019)
Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR.
Nature Medicine
, 25
pp. 1408-1414.
10.1038/s41591-019-0549-5.
|
Gökbuget, N;
Kantarjian, HM;
Brüggemann, M;
Stein, AS;
Bargou, RC;
Dombret, H;
Fielding, AK;
... Topp, MS; + view all
(2019)
Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemia.
Blood Advances
, 3
(20)
pp. 3033-3037.
10.1182/bloodadvances.2019000457.
|
Goswami, P;
Oliva, EN;
Ionova, T;
Else, R;
Kell, J;
Fielding, AK;
Jennings, DM;
... Salek, S; + view all
(2019)
Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology: an equivalence study.
Journal Of Comparative Effectiveness Research
, 8
(7)
pp. 523-533.
10.2217/cer-2018-0108.
|
Gupta, RK;
Abdul-Jawad, S;
McCoy, LE;
Mok, HP;
Peppa, D;
Salgado, M;
Martinez-Picado, J;
... Olavarria, E; + view all
(2019)
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation.
Nature
, 568
pp. 244-249.
10.1038/s41586-019-1027-4.
|
H
Hamilton, N;
Hynds, R;
Gowers, K;
Tait, A;
Butler, C;
Hopper, C;
Burns, A;
... Janes, SM; + view all
(2019)
Using a 3D collagen matrix to deliver respiratory progenitor cells to decellularized trachea in vivo.
Tissue Engineering Part C: Methods
, 25
(2)
pp. 93-102.
10.1089/ten.TEC.2018.0241.
|
Henninger, B;
Alustiza, J;
Garbowski, M;
Gandon, Y;
(2019)
Practical guide to quantification of hepatic iron with MRI.
European Radiology
10.1007/s00330-019-06380-9.
|
Henry, Jake Yarren;
(2019)
Innate lymphoid-macrophage crosstalk promotes lung cancer regression in response to IL-12 therapy.
Doctoral thesis (Ph.D), UCL (University College London).
|
Hostettler, IC;
Bernal-Quiros, M;
Wong, A;
Sharma, N;
Wilson, D;
Seiffge, D;
Shakeshaft, C;
... Houlden, H; + view all
(2019)
C9orf72 and intracerebral haemorrhage.
Neurobiology of Aging
, 84
237.e1-237.e3.
10.1016/j.neurobiolaging.2019.07.007.
|
Howard, J;
Hemmaway, CJ;
Telfer, P;
Layton, DM;
Porter, J;
Awogbade, M;
Mant, T;
... Lehrer-Graiwer, J; + view all
(2019)
A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease.
Blood
, 133
(17)
pp. 1865-1875.
10.1182/blood-2018-08-868893.
|
Hughes, D;
Mikosch, P;
Belmatoug, N;
Carubbi, F;
Cox, T;
Goker-Alpan, O;
Kindmark, A;
... Deegan, P; + view all
(2019)
Gaucher Disease in Bone: From Pathophysiology to Practice.
Journal of Bone and Mineral Research
, 34
(6)
pp. 996-1013.
10.1002/jbmr.3734.
|
Hughes, DA;
Nicholls, K;
Sunder-Plassmann, G;
Jovanovic, A;
Feldt-Rasmussen, U;
Schiffmann, R;
Giugliani, R;
... Bichet, DG; + view all
(2019)
Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study.
American Journal of Medical Genetics: Part A
10.1002/ajmg.a.61105.
(In press).
|
I
Iveson, T;
Boyd, KA;
Kerr, RS;
Robles-Zurita, J;
Saunders, MP;
Briggs, AH;
Cassidy, J;
... Paul, J; + view all
(2019)
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
Health Technology Assessment
, 23
(64)
pp. 1-88.
10.3310/hta23640.
|
J
Joharatnam-Hogan, N;
Cafferty, F;
Hubner, R;
Swinson, D;
Sothi, S;
Gupta, K;
Falk, S;
... Add-Aspirin Trial Management Group; + view all
(2019)
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial.
The Lancet Gastroenterology & Hepatology
, 4
(11)
pp. 854-862.
10.1016/S2468-1253(19)30289-4.
|
Joshi, K;
Robert de Massy, M;
Ismail, M;
Reading, JL;
Uddin, I;
Woolston, A;
Hatipoglu, E;
... Chain, B; + view all
(2019)
Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer.
Nature Medicine
, 25
pp. 1549-1559.
10.1038/s41591-019-0592-2.
|
K
Kenten, C;
Ngwenya, N;
Gibson, F;
Flatley, M;
Jones, L;
Pearce, S;
Wong, G;
... Whelan, J; + view all
(2019)
Understanding care when cure is not likely for young adults who face cancer: a realist analysis of data from patients, families and healthcare professionals.
BMJ Open
, 9
(1)
, Article e024397. 10.1136/bmjopen-2018-024397.
|
Kim, M;
Torrealdea, F;
Adeleke, O;
Rega, M;
Evans, V;
Beeston, T;
Soteriou, K;
... Golay, X; + view all
(2019)
Challenges in glucoCEST MR body imaging at 3 Tesla.
Quantitative Imaging in Medicine and Surgery
, 9
(10)
pp. 1628-1640.
10.21037/qims.2019.10.05.
|
Knott, KD;
Augusto, JB;
Nordin, S;
Kozor, R;
Camaioni, C;
Xue, H;
Hughes, RK;
... Moon, JC; + view all
(2019)
Quantitative Myocardial Perfusion in Fabry Disease.
Circulation: Cardiovascular Imaging
, 12
(7)
, Article e008872. 10.1161/CIRCIMAGING.119.008872.
|
Kolovos, S;
Nador, G;
Kishore, B;
Streetly, M;
Rabin, NK;
Chantry, AD;
Yong, K;
... Pinedo-Villanueva, R; + view all
(2019)
Unplanned admissions for patients with myeloma in the UK: Low frequency but high costs.
Journal of Bone Oncology
, 17
, Article 100243. 10.1016/j.jbo.2019.100243.
|
Koonyosying, P;
Uthaipibull, C;
Fucharoen, S;
Koumoutsea, EV;
Porter, JB;
Srichairatanakool, S;
(2019)
Decrement in Cellular Iron and Reactive Oxygen Species, and Improvement of Insulin Secretion in a Pancreatic Cell Line Using Green Tea Extract.
Pancreas
, 48
(5)
pp. 636-643.
10.1097/MPA.0000000000001320.
|
L
Le Quellec, S;
Dane, A;
Enjolras, N;
McIntosh, J;
Rosales, C;
Negrier, C;
Nathwani, A;
(2019)
Potential limits of AAV-based gene therapy with the use of new transgenes expressing factor IX fusion proteins.
Haemophilia
, 25
(1)
E11-E18.
10.1111/hae.13651.
|
Leija-Salazar, M;
Sedlazeck, FJ;
Toffoli, M;
Mullin, S;
Mokretar, K;
Athanasopoulou, M;
Donald, A;
... Proukakis, C; + view all
(2019)
Evaluation of the detection of GBA missense mutations and other variants using the Oxford Nanopore MinION.
Molecular Genetics & Genomic Medicine
10.1002/mgg3.564.
(In press).
|
M
Manwani, R;
Mahmood, S;
Sachchithanantham, S;
Lachmann, HJ;
Gillmore, JD;
Yong, K;
Rabin, N;
... Wechalekar, AD; + view all
(2019)
Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy.
British Journal of Haematology
, 187
(5)
pp. 638-641.
10.1111/bjh.16122.
|
Marzolini, Maria Ann Veronica;
(2019)
The characterisation and manipulation of a novel subset of tumour-reactive CD4+ cytotoxic T lymphocytes in human cancer.
Doctoral thesis (Ph.D), UCL (University College London).
|
Marzolini, MAV;
Jaunmuktane, Z;
Roddie, C;
O'Reilly, M;
Chiodini, P;
Peggs, KS;
(2019)
Toxoplasmosis initially presenting as neurological sequelae of chimeric antigen receptor T-cell therapy.
The Lancet Infectious Diseases
, 19
(7)
p. 788.
10.1016/S1473-3099(19)30119-7.
|
Mateos, M-V;
Ludwig, H;
Bazarbachi, A;
Beksac, M;
Bladé, J;
Boccadoro, M;
Cavo, M;
... Sonneveld, P; + view all
(2019)
Insights on Multiple Myeloma Treatment Strategies.
HemaSphere
, 3
(1)
, Article e163. 10.1097/HS9.0000000000000163.
|
Mayor, NP;
Hayhurst, JD;
Turner, TR;
Szydlo, RM;
Shaw, BE;
Bultitude, WP;
Sayno, J-R;
... Marsh, SGE; + view all
(2019)
Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study.
Biology of Blood and Marrow Transplantation
, 25
(3)
pp. 443-450.
10.1016/j.bbmt.2018.12.768.
|
McDonnell, T;
Wincup, C;
Buchholz, I;
Pericleous, C;
Giles, I;
Ripoll, V;
Cohen, H;
... Rahman, A; + view all
(2019)
The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS.
Blood Reviews
, Article 100610. 10.1016/j.blre.2019.100610.
|
Mehta, A;
Kuter, DJ;
Salek, SS;
Belmatoug, N;
Bembi, B;
Bright, J;
vom Dahl, S;
... Zimran, A; + view all
(2019)
Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative.
Internal Medicine Journal
, 49
(5)
pp. 578-591.
10.1111/imj.14156.
|
Mekkaoui, L;
Ferrari, M;
Mattiuzzo, G;
Ma, B;
Nannini, F;
Onuoha, S;
Kotsopoulou, E;
... Pule, M; + view all
(2019)
Generation of a neutralizing antibody against RD114-pseudotyped viral vectors.
Journal of General Virology
10.1099/jgv.0.001309.
(In press).
|
Menares, E;
Gálvez-Cancino, F;
Cáceres-Morgado, P;
Ghorani, E;
López, E;
Díaz, X;
Saavedra-Almarza, J;
... Lladser, A; + view all
(2019)
Tissue-resident memory CD8⁺ T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells.
Nature Communications
, 10
(1)
, Article 4401. 10.1038/s41467-019-12319-x.
|
Miles, A;
Taylor, SA;
Evans, REC;
Halligan, S;
Beare, S;
Bridgewater, J;
Goh, V;
... Yu, D; + view all
(2019)
Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment.
European Radiology
, 29
(7)
pp. 3889-3900.
10.1007/s00330-019-06153-4.
|
Mohty, M;
Cavo, M;
Fink, L;
Gonzalez-McQuire, S;
Leleu, H;
Mateos, M-V;
Raab, MS;
... Yong, K; + view all
(2019)
Understanding mortality in multiple myeloma: Findings of a European retrospective chart review.
European Journal of Haematology
, 103
(2)
pp. 107-115.
10.1111/ejh.13264.
|
Morris, EC;
Tendeiro-Rego, R;
Richardson, R;
Fox, TA;
Sillito, F;
Holler, A;
Thomas, S;
... Stauss, H; + view all
(2019)
A Phase I Study Evaluating the Safety and Persistence of Allorestricted WT1-TCR Gene Modified Autologous T Cells in Patients with High-Risk Myeloid Malignancies Unsuitable for Allogeneic Stem Cell Transplantation.
Presented at: 61st ASH Annual Meeting, Orlando, FL, USA.
|
Mullin, S;
Beavan, M;
Bestwick, J;
McNeill, A;
Proukakis, C;
Cox, T;
Hughes, D;
... Schapira, AHV; + view all
(2019)
Evolution and clustering of prodromal parkinsonian features in GBA1 carriers.
Movement Disorders
, 34
(9)
pp. 1365-1373.
10.1002/mds.27775.
|
N
Nordin, S;
Kozor, R;
Vijapurapu, R;
Augusto, JB;
Knott, KD;
Captur, G;
Treibel, TA;
... Moon, JC; + view all
(2019)
Myocardial Storage, Inflammation, and Cardiac Phenotype in Fabry Disease After One Year of Enzyme Replacement Therapy.
Circulation: Cardiovascular Imaging
, 12
(12)
, Article e009430. 10.1161/CIRCIMAGING.119.009430.
|
O
O'Reilly, MA;
Govender, D;
Kirkwood, AA;
Vora, A;
Samarasinghe, S;
Khwaja, A;
Grandage, V;
... O'Connor, D; + view all
(2019)
The incidence of invasive fungal infections in children, adolescents and young adults with acute lymphoblastic leukaemia/lymphoma treated with the UKALL2011 protocol: a multicentre retrospective study.
[Letter].
British Journal of Haematology
, 186
(2)
pp. 327-329.
10.1111/bjh.15798.
|
Ovcinnikovs, V;
Ross, EM;
Petersone, L;
Edner, NM;
Heuts, F;
Ntavli, E;
Kogimtzis, A;
... Walker, LSK; + view all
(2019)
CTLA-4-mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells.
Science Immunology
, 4
(35)
, Article eaaw0902. 10.1126/sciimmunol.aaw0902.
|
P
Popat, R;
Brown, SR;
Flanagan, L;
Hall, A;
Gregory, W;
Kishore, B;
Streetly, M;
... Cavenagh, J; + view all
(2019)
Extended follow‐up and the feasibility of Panobinostat maintenance for patients with Relapsed Multiple Myeloma treated with Bortezomib, Thalidomide, Dexamethasone plus Panobinostat (MUK six open label, multi‐centre phase I/II Clinical Trial).
British Journal of Haematology
, 185
(3)
pp. 573-578.
10.1111/bjh.15551.
|
Primrose, JN;
Fox, RP;
Palmer, DH;
Malik, HZ;
Prasad, R;
Mirza, D;
Anthony, A;
... Bridgewater, J; + view all
(2019)
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.
Lancet Oncology
, 20
(5)
pp. 663-673.
10.1016/S1470-2045(18)30915-X.
|
Proctor, Toby Joseph;
(2019)
Translational process engineering for tissue engineered hollow organ advanced therapy investigational medicinal products.
Doctoral thesis (Eng.D), UCL (University College London).
|
Pugh, G;
Hough, R;
Gravestock, H;
Davies, C;
Horder, R;
Fisher, A;
(2019)
The development and user evaluation of health behaviour change resources for teenage and young adult Cancer survivors.
Research Involvement and Engagement
, 5
, Article 9. 10.1186/s40900-019-0142-6.
|
Pugh, G;
Hough, R;
Gravestock, H;
Fisher, A;
(2019)
The health behaviour status of teenage and young adult cancer patients and survivors in the United Kingdom.
Support Care Cancer
10.1007/s00520-019-04719-y.
(In press).
|
Pugh, G;
Hough, R;
Hubbard, G;
Banks, E;
Fisher, A;
(2019)
Sun exposure among teenage and young adult cancer survivors in the United Kingdom.
Pediatric Blood & Cancer
, 66
(1)
, Article e27424. 10.1002/pbc.27424.
|
R
Raab, MS;
Fink, L;
Schoen, P;
Gonzalez-McQuire, S;
Flinois, A;
Cavo, M;
Mateos, M-V;
(2019)
Evolution of multiple myeloma treatment practices in Europe from 2014 to 2016.
British Journal of Haematology
, 185
(5)
pp. 981-984.
10.1111/bjh.15680.
|
Radin, M;
Sciascia, S;
Erkan, D;
Pengo, V;
Tektonidou, MG;
Ugarte, A;
Meroni, P;
... APS ACTION; + view all
(2019)
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.
Seminars in Arthritis and Rheumatism
, 49
(3)
pp. 464-468.
10.1016/j.semarthrit.2019.04.009.
|
Rahman, S;
Mansour, MR;
(2019)
The role of noncoding mutations in blood cancers.
Disease Models & Mechanisms
, 12
(11)
, Article dmm041988. 10.1242/dmm.041988.
|
Ramirez, GA;
Efthymiou, M;
Isenberg, DA;
Cohen, H;
(2019)
Under crossfire: thromboembolic risk in systemic lupus erythematosus.
Rheumatology
, 58
(6)
pp. 940-952.
10.1093/rheumatology/key307.
|
Recino, A;
Gan, SU;
Sia, KC;
Sawyer, Y;
Trendell, J;
Kay, R;
Gribble, FM;
... Wallberg, M; + view all
(2019)
Immunosuppression overcomes insulin- and vector-specific immune responses that limit efficacy of AAV2/8-mediated insulin gene therapy in NOD mice.
Gene Therapy
, 26
pp. 40-56.
10.1038/s41434-018-0052-5.
|
Reed-Berendt, R;
Shafran, R;
Langdon, D;
Christie, D;
Hough, R;
Coughtrey, A;
(2019)
Experiences of Low Mood in Young People With Cancer: A Qualitative Study.
Journal of Pediatric Oncology Nursing
10.1177/1043454219844232.
(In press).
|
Rego, RT;
Morris, EC;
Lowdell, MW;
(2019)
T-cell receptor gene-modified cells: past promises, present methodologies and future challenges.
Cytotherapy
, 21
(3)
pp. 341-357.
10.1016/j.jcyt.2018.12.002.
|
Richardson, S;
Brian, D;
Grandage, V;
Hough, R;
Kottaridis, P;
Mansour, M;
Payne, EMC;
(2019)
Intensive Chemotherapy Is Associated With Poor Overall Survival in Autoimmune Disease-associated Myeloid Malignancies.
HemaSphere
, 3
(1)
, Article e164. 10.1097/HS9.0000000000000164.
|
Roddie, C;
O'Reilly, M;
Dias Alves Pinto, J;
Vispute, K;
Lowdell, M;
(2019)
Manufacturing chimeric antigen receptor T cells: issues and challenges.
Cytotherapy
, 21
(3)
pp. 327-340.
10.1016/j.jcyt.2018.11.009.
|
Ros-Soto, J;
Snowden, JA;
Salooja, N;
Gilleece, M;
Parker, A;
Greenfield, DM;
Anthias, C;
... Transplant Complications Working Party of the EBMT; + view all
(2019)
Current Practice in Vitamin D Management in Allogeneic Hematopoietic Stem Cell Transplantation: A Survey by the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation.
Biology of Blood and Marrow Transplantation
, 25
(10)
pp. 2079-2085.
10.1016/j.bbmt.2019.06.015.
|
Rosenthal, R;
Cadieux, EL;
Salgado, R;
Bakir, MA;
Moore, DA;
Hiley, CT;
Lund, T;
... TRACERx consortium; + view all
(2019)
Neoantigen-directed immune escape in lung cancer evolution.
Nature
10.1038/s41586-019-1032-7.
(In press).
|
Rule, S;
Cook, G;
Russell, NH;
Hunter, A;
Robinson, S;
Morley, N;
Sureda, A;
... Peggs, KS; + view all
(2019)
Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma.
British Journal of Haematology
, 184
(6)
pp. 999-1005.
10.1111/bjh.15723.
|
Russell, SJ;
Babovic-Vuksanovic, D;
Bexon, A;
Cattaneo, R;
Dingli, D;
Dispenzieri, A;
Deyle, DR;
... Peng, K-W; + view all
(2019)
Oncolytic Measles Virotherapy and Opposition to Measles Vaccination.
Mayo Clinic Proceedings
, 94
(9)
pp. 1834-1839.
10.1016/j.mayocp.2019.05.006.
|
Ryan, SG;
Butler, MN;
Adeyemi, SS;
Kalber, T;
Patrick, PS;
Zaw Thin, M;
Harrison, IF;
... Lythgoe, MF; + view all
(2019)
Imaging of X-Ray-Excited Emissions from Quantum Dots and Biological Tissue in Whole Mouse.
Scientific Reports
, 9
, Article 19223. 10.1038/s41598-019-55769-5.
|
S
Sabry, M;
Zubiak, A;
Hood, SP;
Simmonds, P;
Arellano-Ballestero, H;
Cournoyer, E;
Mashar, M;
... Lowdell, MW; + view all
(2019)
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures.
PLoS One
, 14
(6)
, Article e0218674. 10.1371/journal.pone.0218674.
|
Sammaraiee, Y;
Banerjee, G;
Farmer, S;
Hylton, B;
Cowley, P;
Eleftheriou, P;
Porter, J;
(2019)
Risks associated with oral deferiprone in the treatment of infratentorial superficial siderosis.
Journal of Neurology
, 267
, Article 682. 10.1007/s00415-019-09577-6.
|
Schiffmann, R;
Goker-Alpan, O;
Holida, M;
Giraldo, P;
Barisoni, L;
Colvin, RB;
Jennette, CJ;
... Hughes, D; + view all
(2019)
Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1-year Phase 1/2 clinical trial.
Journal of Inherited Metabolic Disease
, 42
(3)
pp. 534-544.
10.1002/jimd.12080.
|
Schols, S;
Nunn, MA;
Mackie, I;
Weston-Davies, W;
Nishimura, J-I;
Kanakura, Y;
Blijlevens, N;
... Langemeijer, S; + view all
(2019)
Successful treatment of a PNH patient non-responsive to eculizumab with the novel complement C5 inhibitor coversin (nomacopan).
British Journal of Haematology
, 188
(2)
pp. 334-337.
10.1111/bjh.16305.
|
Sciascia, S;
Willis, R;
Pengo, V;
Krilis, S;
Andrade, D;
Tektonidou, MG;
Ugarte, A;
... APS ACTION, .; + view all
(2019)
The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis.
Thrombosis Research
, 175
pp. 32-36.
10.1016/j.thromres.2019.01.010.
|
Sellar, RS;
Mehra, V;
Fox, TA;
Grigg, A;
Kulasekararaj, A;
Sarma, A;
de Lavallade, H;
... Potter, VT; + view all
(2019)
Comparative analysis of melphalan versus busulphan T-cell deplete conditioning using alemtuzumab in unrelated donor stem cell transplantation for acute myeloid leukaemia.
British Journal of Haematology
, 187
(1)
e20-e24.
10.1111/bjh.16136.
|
Stowe, CL;
Burley, TA;
Allan, H;
Vinci, M;
Kramer-Marek, G;
Ciobota, DM;
Parkinson, GN;
... Pule, MA; + view all
(2019)
Near-infrared dual bioluminescence imaging in mouse models of cancer using infraluciferin.
eLife
, 8
, Article e45801. 10.7554/eLife.45801.
(In press).
|
Strauss, VY;
Shaw, R;
Virdee, PS;
Hurt, CN;
Ward, E;
Tranter, B;
Patel, N;
... Mukherjee, S; + view all
(2019)
Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2).
BMC Cancer
, 19
, Article 121. 10.1186/s12885-019-5307-z.
|
Suzuki, E;
Bridgewater, J;
(2019)
Adjuvant therapy for resected gallbladder cancer.
Chinese Clinical Oncology
, 8
(4)
, Article 39. 10.21037/cco.2019.07.02.
|
T
Taher, AT;
Origa, R;
Perrotta, S;
Kouraklis, A;
Belhoul, K;
Huang, V;
Han, J;
... Porter, JB; + view all
(2019)
Influence of patient-reported outcomes on the treatment effect of deferasirox film-coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysis.
[Letter].
American Journal of Hematology
, 94
(4)
E96-E99.
10.1002/ajh.25408.
|
Taher, AT;
Weber, S;
Han, J;
Bruederle, A;
Porter, JB;
(2019)
Predicting serum ferritin levels in patients with iron overload treated with the film-coated tablet of deferasirox during the ECLIPSE study.
American Journal of Hematology
, 94
(1)
E15-E17.
10.1002/ajh.25322.
|
Taylor, SA;
Mallett, S;
Ball, S;
Beare, S;
Bhatnagar, G;
Bhowmik, A;
Boavida, P;
... Streamline investigators; + view all
(2019)
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial.
Lancet Respiratory Medicine
10.1016/S2213-2600(19)30090-6.
(In press).
|
Taylor, SA;
Mallett, S;
Beare, S;
Bhatnagar, G;
Blunt, D;
Boavida, P;
Bridgewater, J;
... Streamline investigators; + view all
(2019)
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial.
The Lancet Gastroenterology & Hepatology
, 4
(7)
pp. 529-537.
10.1016/S2468-1253(19)30056-1.
|
Taylor, SA;
Mallett, S;
Bhatnagar, G;
Morris, S;
Quinn, L;
Tomini, F;
Miles, A;
... Halligan, S; + view all
(2019)
Magnetic resonance enterography compared with ultrasonography in newly diagnosed and relapsing Crohn's disease patients: the METRIC diagnostic accuracy study.
Health Technol Assess
, 23
(42)
pp. 1-161.
10.3310/hta23420.
|
Taylor, SA;
Mallett, S;
Miles, A;
Morris, S;
Quinn, L;
Clarke, CS;
Beare, S;
... Halligan, S; + view all
(2019)
Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies.
Health Technology Assessment
, 23
(66)
10.3310/hta23660.
|
Townsend, W;
Leong, S;
Hoskin, P;
Diez, P;
Patrick, P;
Linch, D;
Wong, W-L;
... Ardeshna, K; + view all
(2019)
Treatment of classical Hodgkin lymphoma in young adults aged 18-30 years with a modified paediatric Hodgkin lymphoma protocol. Results of a multicentre phase II clinical trial (CRUK/08/012).
British Journal of Haematology
10.1111/bjh.16296.
(In press).
|
U
Unlu, O;
Erkan, D;
Barbhaiya, M;
Andrade, D;
Nascimento, I;
Rosa, R;
Banzato, A;
... APS ACTION, .; + view all
(2019)
The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody–Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.
Arthritis Care & Research
, 71
(1)
pp. 134-141.
10.1002/acr.23584.
|
V
Vijapurapu, R;
Geberhiwot, T;
Jovanovic, A;
Baig, S;
Nordin, S;
Kozor, R;
Leyva, F;
... Steeds, RP; + view all
(2019)
Study of indications for cardiac device implantation and utilisation in Fabry cardiomyopathy.
Heart
10.1136/heartjnl-2019-315229.
(In press).
|
Vijapurapu, R;
Kozor, R;
Hughes, DA;
Woolfson, P;
Jovanovic, A;
Deegan, P;
Rusk, R;
... Steeds, RP; + view all
(2019)
A randomised controlled trial evaluating arrhythmia burden, risk of sudden cardiac death and stroke in patients with Fabry disease: the role of implantable loop recorders (RaILRoAD) compared with current standard practice.
Trials
, 20
, Article 314. 10.1186/s13063-019-3425-1.
|
Vijapurapu, R;
Nordin, S;
Baig, S;
Liu, B;
Rosmini, S;
Augusto, J;
Tchan, M;
... Kozor, R; + view all
(2019)
Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease.
Heart
10.1136/heartjnl-2018-313699.
(In press).
|
W
Wagner, AK;
Alici, E;
Lowdell, MW;
(2019)
Characterization of human natural killer cells for therapeutic use.
Cytotherapy
, 21
(3)
pp. 315-326.
10.1016/j.jcyt.2018.11.001.
|
Weil, B;
Hanley, PJ;
Lowdell, M;
(2019)
Proposal for the International Society for Cell & Gene Therapy position statement on assays for the quality control and potency assessment of adoptive cellular immunotherapies.
Cytotherapy
, 21
(3)
pp. 367-375.
10.1016/j.jcyt.2019.02.001.
|
Wilson, D;
Ambler, G;
Lee, K-J;
Lim, J-S;
Shiozawa, M;
Koga, M;
Li, L;
... Microbleeds International Collaborative Network, .; + view all
(2019)
Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.
Lancet Neurology
10.1016/S1474-4422(19)30197-8.
(In press).
|
Wilson, D;
Ambler, G;
Shakeshaft, C;
Banerjee, G;
Charidimou, A;
Seiffge, D;
White, M;
... CROMIS-2 collaborators, .; + view all
(2019)
Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA.
BMJ Open
, 9
(7)
, Article e028387. 10.1136/bmjopen-2018-028387.
|
Woolston, A;
Khan, K;
Spain, G;
Barber, LJ;
Griffiths, B;
Gonzalez-Exposito, R;
Hornsteiner, L;
... Gerlinger, M; + view all
(2019)
Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer.
Cancer Cell
, 36
(1)
35-50e9.
10.1016/j.ccell.2019.05.013.
|
Y
Yong, K;
van de Donk, N;
(2019)
Oral proteasome inhibitor maintenance for multiple myeloma.
The Lancet
, 393
(10168)
pp. 204-205.
10.1016/S0140-6736(18)33128-3.
|
Z
Zwi-Dantsis, L;
Wang, B;
Marijon, C;
Zonetti, S;
Ferrini, A;
Massi, L;
Stuckey, DJ;
... Stevens, MM; + view all
(2019)
Remote Magnetic Nanoparticle Manipulation Enables the Dynamic Patterning of Cardiac Tissues.
Advanced Materials
, Article e1904598. 10.1002/adma.201904598.
(In press).
|